IRIS Accounts Production v26.1.10.60 15977293 Board of Directors 25.9.24 30.9.25 30.9.25 false true false false true false Ordinary share 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 15977293 2024-09-24 15977293 2025-09-30 15977293 2024-09-25 2025-09-30 15977293 2024-09-24 15977293 ns15:EnglandWales 2024-09-25 2025-09-30 15977293 ns14:PoundSterling 2024-09-25 2025-09-30 15977293 ns10:Director1 2024-09-25 2025-09-30 15977293 ns10:PrivateLimitedCompanyLtd 2024-09-25 2025-09-30 15977293 ns10:SmallEntities 2024-09-25 2025-09-30 15977293 ns10:AuditExempt-NoAccountantsReport 2024-09-25 2025-09-30 15977293 ns10:SmallCompaniesRegimeForDirectorsReport 2024-09-25 2025-09-30 15977293 ns10:SmallCompaniesRegimeForAccounts 2024-09-25 2025-09-30 15977293 ns10:FullAccounts 2024-09-25 2025-09-30 15977293 ns10:OrdinaryShareClass1 2024-09-25 2025-09-30 15977293 ns10:Director2 2024-09-25 2025-09-30 15977293 ns10:RegisteredOffice 2024-09-25 2025-09-30 15977293 ns5:ShareCapital 2025-09-30 15977293 ns10:OrdinaryShareClass1 2025-09-30

REGISTERED NUMBER: 15977293 (England and Wales)

| Kinsella Aesthetics Academy Limited |

| Unaudited Financial Statements |

| for the Period 25 September 2024 to 30 September 2025 |

| Kinsella Aesthetics Academy Limited (Registered number: 15977293) |

Contents of the Financial Statements

for the Period 25 September 2024 to 30 September 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| Kinsella Aesthetics Academy Limited |

Company Information

for the Period 25 September 2024 to 30 September 2025

| DIRECTORS: | Mr Thomas James Oakes

| Dr Martin James Kinsella

| REGISTERED OFFICE: | Suite 22c

| City Tower

| Piccadilly Plaza

| Manchester

| England

| M1 4BT

| REGISTERED NUMBER: | 15977293 (England and Wales)

| Kinsella Aesthetics Academy Limited (Registered number: 15977293) |

Balance Sheet

30 September 2025

| Notes | £ |

| Current assets

| Cash in hand | 100 |  |

| Total assets less current liabilities | 100 |  |

| Capital and reserves

| Called up share capital | 5 | 100 |  |

| Shareholders' funds | 100 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 June 2026 and were signed on its behalf by:

Dr Martin James Kinsella - Director

| Kinsella Aesthetics Academy Limited (Registered number: 15977293) |

Notes to the Financial Statements

for the Period 25 September 2024 to 30 September 2025

1. | GENERAL INFORMATION

| The company is a private company limited by share capital, incorporated in United Kingdom.

| The address of its registered office is:

| Suite 22c

| City Tower

| Piccadilly Plaza

| Manchester

| England

| M1 4BT

2. | STATEMENT OF COMPLIANCE

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

3. | ACCOUNTING POLICIES

| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND KEY ACCOUNTING ESTIMATES

| The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

| BASIS OF PREPARATION

| These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

| CASH AND CASH EQUIVALENTS

| Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

| SHARE CAPITAL

| Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

4. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was 2 .

5. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal

| value: | £ |

| 100 | Ordinary share | 1 | 100 |  |